Determinants of the cost-effectiveness of intermittent preventive treatment for malaria in infants and children.

<h4>Background</h4>Trials of intermittent preventive treatment in infants (IPTi) and children (IPTc) have shown promising results in reducing malaria episodes but with varying efficacy and cost-effectiveness. The effects of different intervention and setting characteristics are not well...

Full description

Bibliographic Details
Main Authors: Amanda Ross, Nicolas Maire, Elisa Sicuri, Thomas Smith, Lesong Conteh
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2011-04-01
Series:PLoS ONE
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/21490967/?tool=EBI
_version_ 1828975118795145216
author Amanda Ross
Nicolas Maire
Elisa Sicuri
Thomas Smith
Lesong Conteh
author_facet Amanda Ross
Nicolas Maire
Elisa Sicuri
Thomas Smith
Lesong Conteh
author_sort Amanda Ross
collection DOAJ
description <h4>Background</h4>Trials of intermittent preventive treatment in infants (IPTi) and children (IPTc) have shown promising results in reducing malaria episodes but with varying efficacy and cost-effectiveness. The effects of different intervention and setting characteristics are not well known. We simulate the effects of the different target age groups and delivery channels, seasonal or year-round delivery, transmission intensity, seasonality, proportions of malaria fevers treated and drug characteristics.<h4>Methods</h4>We use a dynamic, individual-based simulation model of Plasmodium falciparum malaria epidemiology, antimalarial drug action and case management to simulate DALYs averted and the cost per DALY averted by IPTi and IPTc. IPT cost components were estimated from economic studies alongside trials.<h4>Results</h4>IPTi and IPTc were predicted to be cost-effective in most of the scenarios modelled. The cost-effectiveness is driven by the impact on DALYs, particularly for IPTc, and the low costs, particularly for IPTi which uses the existing delivery strategy, EPI. Cost-effectiveness was predicted to decrease with low transmission, badly timed seasonal delivery in a seasonal setting, short-acting and more expensive drugs, high frequencies of drug resistance and high levels of treatment of malaria fevers. Seasonal delivery was more cost-effective in seasonal settings, and year-round in constant transmission settings. The difference was more pronounced for IPTc than IPTi due to the different proportions of fixed costs and also different assumed drug spacing during the transmission season. The number of DALYs averted was predicted to decrease as a target five-year age-band for IPTc was shifted from children under 5 years into older ages, except at low transmission intensities.<h4>Conclusions</h4>Modelling can extend the information available by predicting impact and cost-effectiveness for scenarios, for outcomes and for multiple strategies where, for practical reasons, trials cannot be carried out. Both IPTi and IPTc are generally cost-effective but could be rendered cost-ineffective by characteristics of the setting, drug or implementation.
first_indexed 2024-12-14T14:15:24Z
format Article
id doaj.art-f746ae67e1b44c78b94091775303b629
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-14T14:15:24Z
publishDate 2011-04-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-f746ae67e1b44c78b94091775303b6292022-12-21T22:58:13ZengPublic Library of Science (PLoS)PLoS ONE1932-62032011-04-0164e1839110.1371/journal.pone.0018391Determinants of the cost-effectiveness of intermittent preventive treatment for malaria in infants and children.Amanda RossNicolas MaireElisa SicuriThomas SmithLesong Conteh<h4>Background</h4>Trials of intermittent preventive treatment in infants (IPTi) and children (IPTc) have shown promising results in reducing malaria episodes but with varying efficacy and cost-effectiveness. The effects of different intervention and setting characteristics are not well known. We simulate the effects of the different target age groups and delivery channels, seasonal or year-round delivery, transmission intensity, seasonality, proportions of malaria fevers treated and drug characteristics.<h4>Methods</h4>We use a dynamic, individual-based simulation model of Plasmodium falciparum malaria epidemiology, antimalarial drug action and case management to simulate DALYs averted and the cost per DALY averted by IPTi and IPTc. IPT cost components were estimated from economic studies alongside trials.<h4>Results</h4>IPTi and IPTc were predicted to be cost-effective in most of the scenarios modelled. The cost-effectiveness is driven by the impact on DALYs, particularly for IPTc, and the low costs, particularly for IPTi which uses the existing delivery strategy, EPI. Cost-effectiveness was predicted to decrease with low transmission, badly timed seasonal delivery in a seasonal setting, short-acting and more expensive drugs, high frequencies of drug resistance and high levels of treatment of malaria fevers. Seasonal delivery was more cost-effective in seasonal settings, and year-round in constant transmission settings. The difference was more pronounced for IPTc than IPTi due to the different proportions of fixed costs and also different assumed drug spacing during the transmission season. The number of DALYs averted was predicted to decrease as a target five-year age-band for IPTc was shifted from children under 5 years into older ages, except at low transmission intensities.<h4>Conclusions</h4>Modelling can extend the information available by predicting impact and cost-effectiveness for scenarios, for outcomes and for multiple strategies where, for practical reasons, trials cannot be carried out. Both IPTi and IPTc are generally cost-effective but could be rendered cost-ineffective by characteristics of the setting, drug or implementation.https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/21490967/?tool=EBI
spellingShingle Amanda Ross
Nicolas Maire
Elisa Sicuri
Thomas Smith
Lesong Conteh
Determinants of the cost-effectiveness of intermittent preventive treatment for malaria in infants and children.
PLoS ONE
title Determinants of the cost-effectiveness of intermittent preventive treatment for malaria in infants and children.
title_full Determinants of the cost-effectiveness of intermittent preventive treatment for malaria in infants and children.
title_fullStr Determinants of the cost-effectiveness of intermittent preventive treatment for malaria in infants and children.
title_full_unstemmed Determinants of the cost-effectiveness of intermittent preventive treatment for malaria in infants and children.
title_short Determinants of the cost-effectiveness of intermittent preventive treatment for malaria in infants and children.
title_sort determinants of the cost effectiveness of intermittent preventive treatment for malaria in infants and children
url https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/21490967/?tool=EBI
work_keys_str_mv AT amandaross determinantsofthecosteffectivenessofintermittentpreventivetreatmentformalariaininfantsandchildren
AT nicolasmaire determinantsofthecosteffectivenessofintermittentpreventivetreatmentformalariaininfantsandchildren
AT elisasicuri determinantsofthecosteffectivenessofintermittentpreventivetreatmentformalariaininfantsandchildren
AT thomassmith determinantsofthecosteffectivenessofintermittentpreventivetreatmentformalariaininfantsandchildren
AT lesongconteh determinantsofthecosteffectivenessofintermittentpreventivetreatmentformalariaininfantsandchildren